BDX vs KMTS · P/E 34, rev $21.84B vs rev $95.1M
Becton Dickinson and Company (BDX) versus Kestra Medical Technologies, Ltd. Common Stock (KMTS) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a medical instruments & supplies company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported KMTS revenue for 2026-04-30 was $95.1M. Net income was -$131.6M. Revenue was up 59.0% from 2025-04-30 to 2026-04-30. KMTS currently screens at market cap $1.24B.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. KMTS currently screens at market cap $1.24B.
Not investment advice. Open the BDX and KMTS stock pages for the full models.
Not investment advice.